Migraine Prevention Research
Explore migraine prevention research, including preventive treatments, clinical trials, Botox and treatment strategies.
-
Nutritional supplements for migraine prevention: evaluating evidence sufficiency and effect modifiers through network meta-analysis, trial sequential analysis, and meta-regression.
Authors: Peng J, Zhou L, Chen Y, Li J, Zhang R Systematic review / meta-analysis
This research looked at how well nutritional supplements can prevent migraines. The study used advanced methods to compare different supplements based on their effectiveness and safety. Researchers gathered data from…
-
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.
Authors: Potrebic S, Tanveer S, Becker WJ, Burch R, Cooke LJ Guideline / consensus
This research paper offers updated guidelines for preventing migraines in adults. A group of experts reviewed recent studies and evidence. They aimed to create clear recommendations for healthcare providers. The…
-
Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.
Authors: Pringsheim T, Smith DB, Tanveer S, Becker WJ, Burch R Guideline / consensus
This systematic review examines the effectiveness of medications for preventing migraines in adults. It aims to provide updated guidelines for clinicians treating migraine patients. A multidisciplinary team reviewed…
-
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.
Authors: Potrebic S, Tanveer S, Becker WJ, Burch R, Cooke LJ Guideline / consensus
This research paper updates guidelines for preventing migraines in adults. A panel of experts reviewed recent studies to create these recommendations. They focused on when to start preventive medications for…
-
Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.
Authors: Pringsheim T, Smith DB, Tanveer S, Becker WJ, Burch R Guideline / consensus
This systematic review examined medications that prevent migraines in adults. It aimed to update guidelines for treating migraine based on recent evidence. A panel of experts reviewed numerous studies on migraine…
-
Pharmacotherapy for chronic migraine prevention: a narrative review.
Authors: Baek Y, Yuan H, Silberstein S Review
Chronic migraine (CM) is a serious condition affecting 1-2% of people. It causes significant pain and can disrupt daily life. This research reviews various treatments for preventing CM. The authors examined studies…
-
OnabotulinumtoxinA for chronic migraine: A real-life multicenter study of 479 patients.
Authors: Waliszewska-Prosół M, Marschollek K, Paczkowska M, Sławek J, Bott-Karoń M Observational study
Chronic migraine (CM) is a tough condition to treat, especially with medication-overuse headache (MOH). This study looked at how well onabotulinumtoxin A (BoNT-A) works for CM. Researchers studied 479 Polish patients…
-
Deprescribing and Anti-CGRP preventive therapy in medication-overuse headache associated with migraine: pathophysiological rationale and single-center real world evidence.
Authors: Sošić M, Rački V, Fajkić A, Jašić M, Belančić A Observational study
Medication-overuse headache (MOH) is a common issue for many migraine sufferers. It happens when people take too much medication for migraines, leading to more headaches. This study looked at a new approach to…
-
The Safety of OnabotulinumtoxinA (OnabotA) During Pregnancy and Breastfeeding: Implications for Chronic Migraines.
Authors: Eladawi S, Koonalintip P, Ngomuo A, Leech E, Thaller M Systematic review / meta-analysis
OnabotulinumtoxinA (OnabotA) is a treatment for chronic migraines. Migraines often affect women during pregnancy and breastfeeding. However, treatment options are limited for these women. This study looked at the…
-
Lomerizine Prophylaxis for Pediatric Migraine: Efficacy and Predictors of Treatment Response-A Retrospective Cohort Study.
Authors: Shimomura H, Tokunaga S, Taniguchi N, Terasaki E, Yoshitake S Observational study
Lomerizine is a medication used to prevent migraines, particularly in children. This study looked at 83 patients aged 18 and younger who received lomerizine. Researchers wanted to see how effective it was in reducing…
-
Efficacy and Safety of Oral Zavegepant in Migraine Prevention: A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Migraine.
Authors: Fountaine RJ, Dubrovin S, Mosher L, Liu J, Shahin MH Clinical trial
This study explored the effectiveness and safety of oral zavegepant for chronic migraine prevention. It involved adults with a history of chronic migraines, experiencing many headache days each month. Participants…
-
Long-term efficacy and predictors of response to greater occipital nerve pulsed radiofrequency in migraine with prior preventive treatment failure.
Authors: Babaoglu G, Dadali S, Sabuncu U, Costu A, Akcaboy EY Observational study
In this study, researchers looked at a treatment for migraines called Greater Occipital Nerve (GON) Pulsed Radiofrequency (PRF). This treatment is for patients who haven't had success with other preventive…
-
Safety and Efficacy of Atogepant for Migraine Prevention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Authors: Akram Nizamani S, Memon R, Iguh C, Ali R, Omomhenle OD Systematic review / meta-analysis
Migraine is a common neurological disorder that can severely affect daily life. Atogepant is a new oral medication designed to prevent migraines. This study reviewed six high-quality trials involving 3,453 patients…
-
Fremanezumab for the preventive treatment of migraine in Chinese adults: A Phase 3, randomized controlled trial with an open-label extension.
Authors: Yu S, Su H, Wang H, Zhang M, Barash S Clinical trial
Fremanezumab is a treatment approved for migraine prevention in many countries. This study focused on its effects in Chinese adults with migraines. Researchers conducted a Phase 3 trial with three groups. One group…
-
Lamotrigine prophylaxis is associated with reduced aura frequency in patients with burdensome migraine aura: a retrospective observational study.
Authors: Uzun S, Frejvall U, Karatas H, Petersson P, Sahin G Observational study
Migraine aura affects about one-third of migraine sufferers. For some, this condition is very disabling. Effective treatments are often lacking for these patients. This study looked at lamotrigine (LTG) as a…
-
Flunarizine and cinnarizine in the prophylaxis of vestibular migraine and migraine-associated menière's disease: An 8-month retrospective study.
Authors: di Santillo LS, Califano L Observational study
This study looked at two treatments for vestibular migraine (VM) and migraine-associated Menière's disease (MAMD). These conditions cause frequent vertigo and can severely affect quality of life. Researchers analyzed…
-
[Pituitary adenylate-cyclase activating polypeptide (PACAP)-targeting treatment as a potential migraine prophylactic therapy].
Authors: Tajti J, Csáti A, Körtési T, Vécsei L, Szok D Review
In migraine prevention, new treatments are being explored that target PACAP. Current options include monoclonal antibodies (mAbs) and other specific drugs. Researchers conducted a review of existing literature on…
-
Association of Serum hs-CRP and TNF-α With Therapeutic Response to Erenumab for Migraine Prevention: A Registry for Migraine (REFORM) Study.
Authors: Karlsson WK, Christensen RH, Al-Khazali HM, Olsen DA, Madsen JS Observational study
This study explored the role of inflammatory markers in predicting migraine treatment success. Researchers focused on two markers: high-sensitivity C-reactive protein and tumor necrosis factor-alpha. They studied…
-
Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy.
Authors: Scuteri D, Naturale MD, Pagliaro M, Brescia A, De Francesco AE Guideline / consensus
Migraine is a challenging neurovascular disorder that can progress to chronic forms. This progression may result in medication-overuse headache, leading to higher healthcare costs. The need for preventive treatments…
-
Real-world assessment of effectiveness and safety of candesartan in migraine prevention: Results of the French FHU InovPain registry.
Authors: Ferrao-Malheiro S, Fabre R, Lanteri-Minet M Observational study
Candesartan is recommended for migraine prevention, but real-world data is limited. This study analyzed adults starting candesartan in the French FHU InovPain registry. Patients were assessed at month 3, month 9, and…
